[1]
|
Hill, N.R., Fatoba, S.T., Oke, J.L., Hirst, J.A., O’Callaghan, C.A., Lasserson, D.S., et al. (2016) Global Prevalence of Chronic Kidney Disease—A Systematic Review and Meta-Analysis. PLoS ONE, 11, e0158765. https://doi.org/10.1371/journal.pone.0158765
|
[2]
|
Kazancioglu, R. (2013) Risk Factors for Chronic Kidney Disease: An Update. Kidney International Supplements, 3, 368-371. https://doi.org/10.1038/kisup.2013.79
|
[3]
|
Vanholder, R., Massy, Z., Argiles, A., Spasovski, G., Verbeke, F. and Lameire, N. (2005) Chronic Kidney Disease as Cause of Cardiovascular Morbidity and Mortality. Nephrology Dialysis Transplantation, 20, 1048-1056. https://doi.org/10.1093/ndt/gfh813
|
[4]
|
Sarnak, M.J. and Levey, A.S. (2000) Epidemiology, Diagnosis, and Management of Cardiac Disease in Chronic Renal Disease. Journal of Thrombosis and Thrombolysis, 10, 169-180. https://doi.org/10.1023/A:1018718727634
|
[5]
|
Baigent, C., Burbury, K. and Wheeler, D. (2000) Premature Cardiovascular Disease in Chronic Renal Failure. The Lancet, 365, 147-152. https://doi.org/10.1016/S0140-6736(00)02456-9
|
[6]
|
Levin, A., Djurdjev, O. and Barrett, B. (1999) Burgess Cardiovascular Disease and Mortality in a Community-Based Cohort with Mild Renal Insufficiency. Kidney International, 56, 2214-2219. https://doi.org/10.1046/j.1523-1755.1999.00773.x
|
[7]
|
Carlisle, E., Ethier, J., Jindal, K., Mendelssohn, D., Tobe, S., Singer, J. and Thompson, C. (2001) Cardiovascular Disease in Patients with Chronic Kidney Disease: Getting to the Heart of the Matter. American Journal of Kidney Diseases, 38, 1398-1407. https://doi.org/10.1053/ajkd.2001.29275
|
[8]
|
Stevens, L.A., Li, S., Wang, C., Huang, C., Becker, B.N., Bomback, A.S., Brown, W.W., Burrows, N.R., Jurkovitz, C.T., McFarlane, S.I., Norris, K.C., Shlipak, M., Whaley-Connell, A.T., Chen, S.C., Bakris, G.L. and McCullough, P.A. (2010) Prevalence of CKD and Comorbid Illness in Elderly Patients in the United States: Results from the Kidney Early Evaluation Program (KEEP). American Journal of Kidney Diseases, 55, S23-S33. https://doi.org/10.1053/j.ajkd.2009.09.035
|
[9]
|
Anavekar, N.S., McMurray, J.J.V., Velazquez, E.J., et al. (2004) Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction. The New England Journal of Medicine, 351, 1285-1295.
|
[10]
|
Go, A.S., Chertow, G.M., Fan, D., et al. (2004) Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization. The New England Journal of Medicine, 351, 1296-1305. https://doi.org/10.1056/NEJMoa041031
|
[11]
|
Shastri, S. and Sarnak, M.J. (2010) Cardiovascular Disease and CKD: Core Curriculum 2010. American Journal of Kidney Diseases, 56, 399-417. https://doi.org/10.1053/j.ajkd.2010.03.019
|
[12]
|
Levin, A. (2003) Clinical Epidemiology of Cardiovascular Disease in Chronic Kidney Disease Prior to Dialysis. Seminars in Dialysis, 16, 101-105. https://doi.org/10.1046/j.1525-139X.2003.16025.x
|
[13]
|
Ritchie, J., Rainone, F., Green, D., et al. (2013) Extreme Elevations in Blood Pressure and All-Cause Mortality in a Referred CKD Population: Results from the Crisis Study. International Journal of Hypertension, 2013, Article ID: 597906. https://doi.org/10.1155/2013/597906
|
[14]
|
Martinez-Castelao, A., Gorriz, J.L., Portoles, J.M., et al. (2011) Baseline Characteristics of Patients with Chronic Kidney Disease Stage 3 and Stage 4 in Spain: The MERENA Observational Cohort Study. BMC Nephrology, 12, 53. https://doi.org/10.1186/1471-2369-12-53
|
[15]
|
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International, 3, 1-150.
|
[16]
|
Zannad, F., Kessler, M., Lehert, P., Grunfeld, J.P., Thuilliez, C., Leizorovicz, A. and Lechat, P. (2006) Prevention of Cardiovascular Events in End-Stage Renal Disease: Results of a Randomized Trial of Fosinopril and Implications for Future Studies. Kidney International, 70, 1317-1324. https://doi.org/10.1038/sj.ki.5001657
|
[17]
|
Berl, T., Hunsicker, L.G., Lewis, J.B., Pfeffer, M.A., Porush, J.G., Rouleau, J.L., Drury, P.L., Esmatjes, E., Hricik, D., Parikh, C.R., Raz, I., Vanhille, P., Wiegmann, T.B., Wolfe, B.M., Locatelli, F., Goldhaber, S.Z., Lewis, E.J., Irbesartan Diabetic Nephropathy Trial. Collaborative Study Group (2003) Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy. Annals of Internal Medicine, 138, 542-549.
|
[18]
|
Kidney Disease Outcomes Quality Initiatives (K/DOQI) (2007) Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. American Journal of Kidney Diseases, 49, S12-S154. https://doi.org/10.1053/j.ajkd.2006.12.005
|
[19]
|
Shepherd, J., Kastelein, J.J., Bittner, V., Deedwania, P., Breazna, A., Dobson, S., Wilson, D.J., Zuckerman, A., Wenger, N.K., TNT (Treating to New Targets) Investigators (2008) Intensive Lipid Lowering with Atorvastatin in Patients with Coronary Heart Disease and Chronic Kidney Disease: The TNT (Treating to New Targets) Study. Journal of the American College of Cardiology, 51, 1448-1454. https://doi.org/10.1016/j.jacc.2007.11.072
|
[20]
|
Parfrey, P.S., Lauve, M., Latremouille-Viau, D. and Lefebvre, P. (2009) Erythropoietin Therapy and Left Ventricular Mass Index in CKD and ESRD Patients: A Meta-Analysis. Clinical Journal of the American Society of Nephrology, 4, 755-762. https://doi.org/10.2215/CJN.02730608
|
[21]
|
Di Lullo, L., Floccari, F., Granata, A. and Malaguti, M. (2012) Low-Dose Treatment with Erythropoiesis-Stimulating Agents and Cardiovascular Geometry in Chronic Kidney Disease: Is Darbepoetin-α More Effective than Expected? Cardiorenal Medicine, 2, 18-25. https://doi.org/10.1159/000334942
|
[22]
|
Kidney Disease Outcomes Quality Initiatives (K/DOQI) (2007) Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. American Journal of Kidney Diseases, 49, S12-S154. https://doi.org/10.1053/j.ajkd.2006.12.005
|
[23]
|
Kidney Disease Outcomes Quality Initiatives (K/DOQI) (2009) Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Treatment of CKD-MBD Targeted at Lowering High Serum Phosphorus and Maintaining Serum Calcium. Kidney International, 76, S50. https://doi.org/10.1038/ki.2009.192
|
[24]
|
Di Lullo, L., Floccari, F., Santoboni, A., Barbera, V., Rivera, R.F., Granata, A., Morrone, L. and Russo, D. (2013) Progression of Cardiac Valve Calcification and Decline of Renal Function in CKD Patients. Journal of Nephrology, 26, 739-744. https://doi.org/10.5301/jn.5000290
|
[25]
|
Collins, A.J., Foley, R.N., Herzog, C., et al. (2010) Excerpts from the US Renal Data System 2009 Annual Data Report. American Journal of Kidney Diseases, 55, S1-A7. https://doi.org/10.1053/j.ajkd.2009.10.009
|
[26]
|
Stanifer, J.W., Jing, B., Tolan, S., Helmke, N., Mukerjee, R., Naicker, S. and Patel, U. (2014) The Epidemiology of Chronic Kidney Disease in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. The Lancet Global Health, 2, 174-181. https://doi.org/10.1016/S2214-109X(14)70002-6
|
[27]
|
Akpan, E.E., Ekrikpo, U.E., Effa, E.E., Udo, A.I.A. and Kadiri, S. (2014) Assessment of Dyslipidemia in Pre-Dialysis Patients in South-West Nigeria. Nigerian Medical Journal, 55, 214-219. https://doi.org/10.4103/0300-1652.132043
|
[28]
|
Tene, U. (2011) The Epidemiologic Profile of Cardiac Diseases in Patients with Non Dialysis Dependent Chronic Kidney Disease [Thesis]. Fac. Med Biomed Sci., Yaounde.
|
[29]
|
Kaze, F.F., Kengne, A.-P., Magatsing, C.T., Halle, M.-P., Yiagnigni, E. and Ngu, K.B. (2016) Prevalence and Determinants of Chronic Kidney Disease among Hypertensive Cameroonians According to Three Common Estimators of the Glomerular Filtration Rate. Journal of Clinical Hypertension, 18, 408-414. https://doi.org/10.1111/jch.12781
|
[30]
|
Kaze, F.F., Halle, M.-P., Mopa, H.T., Ashuntantang, G., Fouda, H., Ngogang, J., et al. (2015) Prevalence and Risk Factors of Chronic Kidney Disease in Urban Adult Cameroonians According to Three Common Estimators of the Glomerular Filtration Rate: A Cross-Sectional Study. BMC Nephrology, 16, Article No. 96. https://doi.org/10.1186/s12882-015-0102-9
|
[31]
|
Halle, M.P., Takongue, C., Kengne, A.P., Kaze, F.F. and Ngu, K.B. (2015) Epidemiological Profile of Patients with End Stage Renal Disease in a Referral Hospital in Cameroon. BMC Nephrology, 16, Article No. 59. https://doi.org/10.1186/s12882-015-0044-2
|
[32]
|
Halle, M.P., Ashuntantang, G., Kaze, F.F., Takongue, C. and Kengne, A.-P. (2016) Fatal Outcomes among Patients on Maintenance Haemodialysis in Sub-Saharan Africa: A 10-Year Audit from the Douala General Hospital in Cameroon. BMC Nephrology, 17, Article No. 165. https://doi.org/10.1186/s12882-016-0377-5
|
[33]
|
Halle, M.P.E., Kengne, A.P. and Ashuntantang, G. (2009) Referral of Patients with Kidney Impairment for Specialist Care in a Developing Country of Sub-Saharan Africa. Renal Failure, 31, 341-348. https://doi.org/10.1080/08860220902882014
|
[34]
|
Levey, A.S. and Stevens, L.A. (2010) Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and Better Risk Predictions. American Journal of Kidney Diseases, 55, 622-627. https://doi.org/10.1053/j.ajkd.2010.02.337
|
[35]
|
Kligfield, et al. (2007) Standardization and Interpretation of the ECG, Part I. Circulation, 115, 1306-1324. https://doi.org/10.1161/CIRCULATIONAHA.106.180200
|
[36]
|
Kidney Disease Outcomes Quality Initiative (K/DOQI) Group (2003) K/DOQI Clinical Practice Guidelines for Managing Dyslipidemias in Chronic Kidney Disease. American Journal of Kidney Diseases, 41, S1-S91.
|
[37]
|
Whitman, I.R., Agarwal, V., Nah, G., et al. (2017) Alcohol Abuse and Cardiac Disease. Journal of the American College of Cardiology, 69, 13-24. https://doi.org/10.1016/j.jacc.2016.10.048
|
[38]
|
Chuang, S.Y., Chen, J.H., Yeh, W.T., Wu, C.C. and Pan, W.H. (2012) Hyperuricemia and Increased Risk of Ischemic Heart Disease in a Large Chinese Cohort. International Journal of Cardiology, 154, 316-321.
|
[39]
|
Armstrong, C. and Joint National Committee (2014) JNC 8 Guidelines for the Management of Hypertension in Adults. American Family Physician, 90, 503-504.
|
[40]
|
KDIGO (2009) KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD). Kidney International Supplements, 76, S1-S130.
|
[41]
|
Sagun, G., Kantarci, G., Mesci, B., Gungor, S., Turkoglu, F., Yorulmaz, E., et al. (2010) Frequency of Cardiovascular Risk Factors and Metabolic Syndrome in Patients with Chronic Kidney Disease. Clinical Medicine & Research, 8, 135-141. https://doi.org/10.3121/cmr.2010.892
|
[42]
|
Foster, M.C., Rawlings, A.M., Marrett, E., Neff, D., Willis, K., Inker, L.A., et al. (2013) Cardiovascular Risk Factor Burden, Treatment, and Control among Adults with Chronic Kidney Disease in the United States. American Heart Journal, 166, 150-156. https://doi.org/10.1016/j.ahj.2013.03.016
|
[43]
|
De Nicola, L., Minutolo, R., Chiodini, P., Zoccali, C., Castellino, P., Donadio, C., et al. (2006) Global Approach to Cardiovascular Risk in Chronic Kidney Disease: Reality and Opportunities for Intervention. Kidney International, 69, 538-545. https://doi.org/10.1038/sj.ki.5000085
|
[44]
|
Morgado, E. and Neves, P.L. (2012) Hypertension and Chronic Kidney Disease: Cause and Consequence—Therapeutic Considerations. In: Babeai, H., Ed., Antihypertensive Drugs, IntechOpen, London, 45-57. https://doi.org/10.5772/36916
|
[45]
|
Kamadjeu, R.M., Edwards, R., Atanga, J.S., Kiawi, E.C., Unwin, N. and Mbanya, J.C. (2006) Anthropometry Measures and Prevalence of Obesity in the Urban Adult Population of Cameroon: An Update from the Cameroon Burden of Diabetes Baseline Survey. BMC Public Health, 6, Article No. 228. https://doi.org/10.1186/1471-2458-6-228
|
[46]
|
Maliha, A. and Riaz, A. (2017) The Rising Prevalence of Obesity; Part A: Impact on Public Health. International Journal of Surgical Oncology, 2, e17. https://doi.org/10.1097/IJ9.0000000000000017
|
[47]
|
Babua, C., Kalyesubula, R., Okello, E., Kakande, B., Sebatta, E., Mungoma, M. and Mondo, C. (2015) Pattern and Presentation of Cardiac Diseases among Patients with Chronic Kidney Disease Attending a National Referral Hospital in Uganda: A Cross Sectional Study. BMC Nephrology, 16, 126. https://doi.org/10.1186/s12882-015-0128-z
|
[48]
|
Major, R.W., et al. (2018) Cardiovascular Disease Risk Factors in Chronic Kidney Disease: A Systematic Review and Meta-Analysis PLoS ONE, 13, e0192895. https://doi.org/10.1371/journal.pone.0192895
|
[49]
|
Chonchol, M., Shlipak, M.G., Katz, R., Sarnak, M.J., Newman, A.B., Siscovick, D.S., et al. (2007) Relationship of Uric Acid with Progression of Kidney Disease. American Journal of Kidney Diseases, 50, 239-247. https://doi.org/10.1053/j.ajkd.2007.05.013
|
[50]
|
Amoako, Y.A. and Laryea, D.O. (2017) Left Ventricular Hypertrophy among Chronic Kidney Disease Patients in Ghana. The Pan African Medical Journal, 28, 79. https://doi.org/10.11604/pamj.2017.28.79.9183
|
[51]
|
Chijioke, A., Makusidi, A.M. and Kolo, P.M. (2012) Electrocardiographic Abnormalities among Dialysis Naïve Chronic Kidney Disease Patients in Ilorin Nigeria. Annals of African Medicine, 11, 21-26. https://doi.org/10.4103/1596-3519.91011
|
[52]
|
Eckardt, K.U., Scherhag, A., Macdoigall, I.C., et al. (2009) Left Ventricular Geometry Predicts Cardiovascular Outcomes Associated with Anemia Correction in CKD. Journal of the American Society of Nephrology, 20, 2651-2660. https://doi.org/10.1681/ASN.2009060631
|
[53]
|
Kaze, F.F., Kengne, A.P., Ashuntantang, G., Halle, M.P., Menanga, A.P., Kingue, S., et al. (2014) Pattern and Correlates of Cardiac Lesions in a Group of Sub-Saharan African Patients on Maintenance Hemodialysis. The Pan African Medical Journal, 17, 3. https://doi.org/10.11604/pamj.2014.17.3.3422
|
[54]
|
Kaze-Folefack, F., Nono, A., Halle, M.P. and Ashuntantang, G. (2015) Severity and Control of Hypertension during Chronic Kidney Disease in Cameroon. Pan African Medical Journal, 21, 205.
|
[55]
|
Lin, T.-H., Chuang, S.-Y., Chu, C.-Y., Lee, W.-H., Hsu, P.-C., Su, H.-M., et al. (2014) The Impact of Chronic Kidney Disease on Lipid Management and Goal Attainment in Patients with Atherosclerosis Diseases in Taiwan. International Journal of Medical Sciences, 11, 381-388. https://doi.org/10.7150/ijms.7069
|
[56]
|
Dzudie, A., Epie, N., Abanda, M., Abanda, M., Aminde, L., Hamadou, B., Dzekem, B., et al. (2020) Availability, Cost and Affordability of Essential Cardiovascular Disease Medicines in the South West Region of Cameroon: Preliminary Findings from the Cameroon Science for Disease Study. PLoS ONE, 15, e0229307. https://doi.org/10.1371/journal.pone.0229307
|
[57]
|
Goicoechea, M., de Vinuesa, S.G., Verdalles, U., Ruiz-Caro, C., Ampuero, J., Rincon, A., et al. (2010) Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk. Clinical Journal of the American Society of Nephrology, 5, 1388-1393. https://doi.org/10.2215/CJN.01580210
|